Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine

NCT04991974 ↗

Phase 2/3 Completed 373 enrolled Friends Research Institute, Inc. Baltimore City Health Department · collab National Institute on Drug Abuse (NIDA) · collab

RandomizedParallel-groupOpen-labelHealth-services research

Summary

This study will examine the effectiveness of opioid use disorder (OUD) treatment linkage strategies for patients identified at sexual health clinics and through community outreach and referrals. This 3-arm RCT will compare Usual Care vs. Patient Navigation vs. Patient Navigation + Buprenorphine Initiation (UC vs. PN vs. PN+BUP).

Timeline

Start: 2021-09-17
Primary completion: 2026-01-31
Completion: 2026-01-31

Publications

Nordeck CD, Sharma A, Terplan M, Dusek K, Gilliams E, Gryczynski J. Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine (OUTLAST-B): Rationale, Design, and Evolution of a Randomized Controlled Trial. J Psychiatr Brain Sci. 2023;8(6):e230010. doi: 10.20900/jpbs.20230010. Epub 2023 Dec 25.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Buprenorphine	Other / unclassified	8 mg	Other
Subject	Buprenorphine	Other / unclassified	16 mg	Other

Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine

Summary

Timeline

Publications

Drugs

Indications